Active substance
Clostridium botulinum type a toxin haemagglutinin complex
- SFDA 2
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| DYSPORT 500U VIAL | 500 U | Powder for injection · intramuscular, subcutaneous | 1 Vial | SAR 947.10 | Biological · Prescription | Ipsen Limited | Valid |
| NABOTA | 100 IU | powder for solution for injection · Intramuscular use | 1 Vial | SAR 391.45 | Biological · Prescription | DAEWOONG PHARMACEUTICAL CO LTD | Valid |
Indications — CHI Daman Drug Formulary
HEMORRHOIDS; HUNTINGTON'S DISEASE-DYSTONIA; SPASTICITY; URINARY INCONTINENCE AND OVERACTIVE BLADDER
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.